Circulating tumor DNA moves further into the spotlight

Assessment of somatic genomic alterations from tumors can now be performed by sequencing circulating tumor DNA from the cell-free component of blood. This procedure, which identifies tumor-derived somatic mutations from a simple blood sample, circumvents the need for tumor tissue. A recent study hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Sausen, Mark, Parpart, Sonya, Diaz, Luis A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062042/
https://www.ncbi.nlm.nih.gov/pubmed/24944584
http://dx.doi.org/10.1186/gm552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062042/
https://www.ncbi.nlm.nih.gov/pubmed/24944584
http://dx.doi.org/10.1186/gm552

Ejemplares similares